Conversion from chronic to episodic migraine in patients treated with erenumab: real-life data from an Italian region | The Journal of Headache and Pain | Full Text

Conversion from chronic to episodic migraine in patients treated with erenumab: real-life data from an Italian region | The Journal of Headache and Pain | Full Text

Conversion from chronic to episodic migraine in patients treated with erenumab: real-life data from an Italian region

Most patients treated with erenumab in clinical practice have chronic migraine (CM). We assessed the rate and possible predictors of conversion from CM to episodic migraine (EM) in a real-life study.

Authors:Raffaele Ornello, Alfonsina Casalena, Ilaria Frattale, Valeria Caponnetto, Amleto Gabriele, Giannapia Affaitati, Maria Adele Giamberardino, Maurizio Assetta, Maurizio Maddestra, Fabio Marzoli, Stefano Viola, Davide Cerone, Carmine Marini, Francesca Pistoia and Simona Sacco

Citation:The Journal of Headache and Pain 2020 21:102

Content type:Short report

 

Published on: 15 August 2020

• ViewFull Text
 
• ViewPDF